Navigation Links
RICE MEMORIAL HOSPITAL PHARMACY STAFF EXPERIENCES A 55% REDUCTION IN TIME SPENT MANAGING PATIENT-SPECIFIC MEDICATIONS USING OMNICELL SINGLEPOINTE SOLUTION
Date:4/17/2008

Findings of pre- and post study at Rice Memorial Hospital translates into

increased efficiency of pharmacist and nursing staff

MOUNTAIN VIEW, Calif. and WILLMAR, Minn., April 17 /PRNewswire-FirstCall/ -- Omnicell, Inc. (Nasdaq: OMCL) a leading provider of system solutions targeting patient safety and operational efficiency in healthcare facilities, and Rice Memorial Hospital, a major healthcare facility in West Central Minnesota, today announced results from a survey administrated to nurses and pharmacists before and after the successful implementation of Omnicell's SinglePointe(TM) offering. The SinglePointe offering is an automated patient-specific medication management solution from Omnicell that provides hospitals with a single point of access for all patient medications that is simpler and safer than existing methods of hospital medication management.

Data at Rice Memorial Hospital was collected pre- and post SinglePointe implementation to look at efficiencies and improvements for pharmacy and nursing. Findings were presented during an educational Omnicell program on Tuesday, April 15, at the Renaissance Charlotte Suites Hotel in Charlotte, NC, by Elizabeth Kadlec, PharmD, Clinical Pharmacist at Rice Memorial Hospital.

"The implementation of the SinglePointe solution allowed us to evaluate our drug distribution process and make changes to improve our internal efficiency," said Kadlec. "Automation of our medication management systems is also increasing patient safety by allowing for profiled access to patient-specific medications."

Kadlec revealed data that indicated the installation of the SinglePointe solution resulted in a fifty-five percent reduction in time required to manage patient-specifi
'/>"/>

SOURCE Omnicell, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Northwestern Memorial Study Tests Cancer Drug on Scleroderma Patients
2. Northwestern Memorial Transplant Program Initiates New Study
3. April 16th Congressional Hearing on Hospital Infections
4. Texas Heart(R) Institute at St. Lukes Episcopal Hospital Initiates First Clinical Trial in the World to Treat a Heart Attack Patient with a Special Stem Cell Type
5. Enanta Reports New Macrolide-Related Drug Class, Bicyclolides, to Combat Hospital and Community Acquired Superbug Infections, Including MRSA
6. Hope for Emphysema Sufferers: Clinical Trial That May Help Patients Breathe Easier Begins at Central DuPage Hospital
7. UMDNJ-University Hospital in Newark to Tailor Diabetes Interventions for Low-Income and Minority Groups With Grant From the International Diabetes Federation
8. First Clinical Volumetric Modulated Arc Therapy Treatment Completed With Elekta Synergy(R) S at General Hospital Vienna
9. Childrens Hospital Cancer Study Finds Adolescents and Young Adults Dont Get Same Access to Cutting-Edge Treatment as Younger Patients
10. DuPont Provides Technology for Washington Hospital Centers Emergency Department
11. Hospital Launches Landmark Emergency Medicine Project
Post Your Comments:
*Name:
*Comment:
*Email: